BIOGNOSYS
Biognosys believe that the decoding of the proteome will impact the life sciences more than the genome revolution a decade ago, and they strive to be the company that enables the routine analysis of proteomes in each research and clinical laboratory worldwide.Biognosys offers a unique next-generation solution for precise quantification of large proteomes in biological samples. Their technology provides unprecedented depth and quality of protein expression data for more effective biomarker and drug-target discovery and validation. Biognosys is a spin-off from the leading proteomics lab of Prof. Ruedi Aebersold, ETH Zurich.
BIOGNOSYS
Industry:
Biotechnology Clinical Trials Communities Genetics Health Care
Founded:
2008-09-02
Address:
Schlieren, Zurich, Switzerland
Country:
Switzerland
Website Url:
http://www.biognosys.com
Total Employee:
101+
Status:
Active
Contact:
41 44 738 20 40
Email Addresses:
[email protected]
Total Funding:
9.03 M USD
Technology used in webpage:
SPF Domain Not Resolving Microsoft Exchange Online Office 365 Mail PHP TransIP DNS Hostpoint
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
PM Equity Partner
PM Equity Partner investment in Series C - Biognosys
Venture Kick
Venture Kick investment in Grant - Biognosys
Venture Kick
Venture Kick investment in Grant - Biognosys
Official Site Inspections
http://www.biognosys.com Semrush global rank: 2.47 M Semrush visits lastest month: 7.19 K
- Host name: sl2012.web.hostpoint.ch
- IP address: 217.26.54.8
- Location: Switzerland
- Latitude: 47.1449
- Longitude: 8.1551
- Timezone: Europe/Zurich
